Asthika Goonewardene
Stock Analyst at Truist Securities
(2.08)
# 3,024
Out of 5,113 analysts
88
Total ratings
42.35%
Success rate
-5.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Initiates: Buy | $40 | $23.25 | +72.04% | 1 | Dec 17, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $43 | $23.10 | +86.15% | 1 | Nov 25, 2025 | |
| GMAB Genmab | Reiterates: Buy | $49 → $48 | $34.40 | +39.53% | 16 | Nov 7, 2025 | |
| GILD Gilead Sciences | Reiterates: Buy | $127 → $145 | $140.97 | +2.86% | 3 | Nov 3, 2025 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $32 → $39 | $22.99 | +69.64% | 2 | Oct 7, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $100 | $14.73 | +578.89% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $99.82 | -0.82% | 1 | Sep 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $43.74 | +12.03% | 11 | Jul 29, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $119.34 | +29.88% | 3 | Jun 3, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $18.27 | +288.62% | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $10 | $1.53 | +553.59% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.42 | +604.23% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.98 | +403.36% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $15.90 | +120.13% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $68.57 | +98.34% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $150 | $16.62 | +802.53% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $2.02 | +98.02% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.55 | +1,125.81% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $432 | $8.54 | +4,958.55% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $7.16 | +1,575.98% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.29 | +4,562.00% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $11.12 | +1,518.71% | 4 | Aug 23, 2022 |
Zymeworks
Dec 17, 2025
Initiates: Buy
Price Target: $40
Current: $23.25
Upside: +72.04%
ArriVent BioPharma
Nov 25, 2025
Initiates: Buy
Price Target: $43
Current: $23.10
Upside: +86.15%
Genmab
Nov 7, 2025
Reiterates: Buy
Price Target: $49 → $48
Current: $34.40
Upside: +39.53%
Gilead Sciences
Nov 3, 2025
Reiterates: Buy
Price Target: $127 → $145
Current: $140.97
Upside: +2.86%
Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32 → $39
Current: $22.99
Upside: +69.64%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $14.73
Upside: +578.89%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $99.82
Upside: -0.82%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $43.74
Upside: +12.03%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $119.34
Upside: +29.88%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $18.27
Upside: +288.62%
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.53
Upside: +553.59%
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.42
Upside: +604.23%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.98
Upside: +403.36%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $15.90
Upside: +120.13%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $68.57
Upside: +98.34%
Aug 16, 2024
Maintains: Buy
Price Target: $180 → $150
Current: $16.62
Upside: +802.53%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $2.02
Upside: +98.02%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.55
Upside: +1,125.81%
Sep 6, 2023
Reiterates: Buy
Price Target: $432
Current: $8.54
Upside: +4,958.55%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $7.16
Upside: +1,575.98%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.29
Upside: +4,562.00%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $11.12
Upside: +1,518.71%